NEW YORK (GenomeWeb News) - Regeneron Pharmaceuticals has teamed with Geisinger Health System of Pennsylvania in a project that will use genomic analysis to study 100,000 patients with the aim of improving drug development and patient care capabilities, the partners said on Monday.

Regeneron will conduct its end of the partnership out of a new subsidiary, the Regeneron Genetics Center, located in Tarrytown, NY.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: methylation patterns in multiple myeloma, recent Y chromosome bottleneck, and more.

By studying the spectra of microbes on Earth, a team of researchers hopes to be better equipped to detect any on other worlds.

SolveBio's Mark Kaganovich says at TechCrunch that genomics needs an app to push it into the mainstream.

A University of Michigan team is using a Facebook app to recruit and keep in touch with participants in its 'Genes for Good' project.

Apr
15
Sponsored by
WaferGen

This live online seminar will highlight recent trends in applying next-generation sequencing in the clinical setting, with a particular focus on oncology and rare disease.